Trastuzumab-EU
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trastuzumab-EU, covering 2018-01-23 to 2018-01-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02) [Phase 3]